IO Biotech Total Current Liabilities

IO Biotech (IOBT) currently reports a total current liabilities of $18M as of September 2025. That compares with $16M in the prior-year period — up 14.1% year over year. Use the charts on this page to explore IO Biotech's total current liabilities history and peer comparisons.

IO Biotech's total current liabilities increased from $16M to $18M — a 14.1% year-over-year increase (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

IO Biotech reported $18M in total current liabilities as of September 2025. That compares with $16M in the prior-year period — up 14.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $18M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for IO Biotech, and consider following IOBT for alerts when major investors trade the stock.